Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
William Johnston Scott,Ningshu Liu,Manfred Möwes,Andrea Hägebarth,Ursula Mönning,Ulf Bömer
申请号：
US13885122
公开号：
US08895549B2
申请日:
2011.11.08
申请国别(地区):
US
年份:
2014
代理人:
摘要：
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
